Tag: small animal imaging in vivo market top players

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Small Animal Imaging (In-Vivo) Market Revenue Growth On Track For A 11.8% CAGR Through 2030

The small animal imaging (in-vivo) market has experienced rapid expansion in recent years. This market is projected to grow from $3.15 billion in 2025 to $3.54 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.4%. The historical increase in this market can be attributed to several factors, including an uptick in preclinical research activities, a rise in drug discovery investments, expanded funding for academic research, the increasing adoption of animal models in disease studies, and the availability of advanced imaging modalities.

The small animal imaging (in-vivo) market size is anticipated to experience substantial growth in the coming years. It is forecast to expand to $5.53 billion by 2030, achieving a compound annual growth rate (CAGR) of 11.8%. This expansion during the forecast period is driven by factors such as the increasing need for precision medicine research tools, rising investments in translational research, the broadening of oncology and neurological studies, the growing adoption of AI-assisted diagnostics, and a heightened focus on real-time biological imaging. Prominent trends observed in this period include the increased adoption of multimodal imaging systems, a rise in the use of non-invasive in vivo imaging techniques, the expanding integration of AI-based image analysis, the extension of longitudinal disease monitoring studies, and an enhanced emphasis on high-resolution imaging capabilities.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=64795793&type=smp&name=Small%20Animal%20Imaging%20%28In-Vivo%29%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Small Animal Imaging (In-Vivo) Market Development Factors: What’s Supporting Demand?

The small animal imaging (in vivo) market is projected to grow as a result of increasing spending in the healthcare sector. Healthcare expenditure refers to the total public and private costs for health care as a percentage of GDP. The rise in healthcare expenditure along with greater healthcare awareness promotes the idea of self-care management, a practice where PET equipment is utilized in techniques such as small animal imaging. Small animal imaging (in vivo) benefits the healthcare sector by allowing for noninvasive, real-time visualization of biological processes, accelerating the development of drugs, improving comprehension of diseases, and assisting in the creation of more effective therapies. For instance, in May 2024, a report from the Office for National Statistics, a UK-based government statistical organization, revealed that healthcare spending in the UK rose by 5.6% in nominal terms in 2023, with long-term health and social care expenditure seeing a 2.8% increase in real terms in 2022. Hence, the increasing financial investment in the healthcare sector is fueling the expansion of the small animal imaging (in-vivo) market.

Small Animal Imaging (In-Vivo) Market Segment Landscape: Which Areas Lead Development?

The small animal imaging (in-vivo) market covered in this report is segmented –

1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components

2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics

3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers

Subsegments:

1) By Micro-MRI: High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents

2) By Optical Imaging: In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems

3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers

4) By Other Components: X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems

Small Animal Imaging (In-Vivo) Market Transformation Trends: What Innovations Are Driving Change?

Major companies within the small animal imaging (In-Vivo) market are increasingly prioritizing sophisticated in vivo imaging software platforms, such as modules for real-time kinetic analysis. This emphasis aims to address the growing need for more precise, quantitative, and efficient preclinical research in areas like oncology and neuroscience. These platforms facilitate the continuous capture and automated examination of dynamic bioluminescent (BLI) signals across time, diverging from conventional static single-timepoint observations. This approach results in more comprehensive kinetic curves, enhanced reproducibility, and improved identification of crucial peak signal stages. An illustrative example occurred in April 2024, when Spectral Instruments Imaging, a US-based preclinical imaging technology company, unveiled Aura 4.5. This release represents the newest iteration of its in vivo imaging software. Aura 4.5 incorporates a Kinetics mode, which allows for automated, real-time collection of bioluminescent signals throughout their entire time course, encompassing the rise, plateau, and decay phases. Subsequently, the software pinpoints and reports the peak bioluminescent intensity, thereby assisting researchers in optimizing sensitivity and biological accuracy. Furthermore, it streamlines the process of data acquisition and minimizes the need for manual intervention, consequently boosting workflow efficiency for longitudinal investigations. This feature-rich enhancement proves particularly beneficial for longitudinal, time-sensitive studies, including pharmacokinetics, gene expression, or infection models.

Small Animal Imaging (In-Vivo) Market Competitive Analysis Of Leading Industry Participants

Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation

View The Full Small Animal Imaging (In-Vivo) Market Report:

https://thebusinessresearchcompany.com/report/small-animal-imaging-In-Vivo-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Small Animal Imaging (In-Vivo) Market Geographic Distribution And Regional Opportunities

North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The small animal imaging (in-vivo) market has experienced impressive expansion in recent years, driven by advancements in research and technology. This growing sector plays a critical role in preclinical studies and drug discovery, and its future looks promising with ongoing innovations and increased investments. Below is an in-depth review of the market size, key drivers, industry trends, major players, and regional growth prospects shaping this dynamic field.

Current Market Size and Projected Growth in the Small Animal Imaging (In-Vivo) Market

The small animal imaging (in-vivo) market has witnessed rapid development, with its value rising from $3.15 billion in 2025 to an anticipated $3.54 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.4%. This historical growth has been fueled by an uptick in preclinical research activities, greater investments in drug discovery, increased funding for academic research, expanded use of animal models in disease exploration, and the availability of advanced imaging technologies. Looking ahead, the market is projected to reach $5.53 billion by 2030, growing at a CAGR of 11.8%. Factors expected to drive this growth include the rising demand for precision medicine tools, increased funding in translational research, expansion of oncology and neurological studies, growing adoption of AI-assisted diagnostic techniques, and heightened emphasis on real-time biological imaging. Key trends influencing the market will involve the adoption of multimodal imaging systems, broader use of non-invasive in vivo imaging methods, integration of AI-based image analysis, expansion of longitudinal disease monitoring, and a focus on enhancing high-resolution imaging capabilities.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp

Healthcare Spending as a Catalyst for Small Animal Imaging (In-Vivo) Market Expansion

A significant factor propelling the small animal imaging (in-vivo) market’s growth is the rising expenditure in the healthcare sector worldwide. Healthcare spending encompasses both public and private costs as a percentage of GDP and reflects growing awareness around health management. This increased investment encourages self-care practices and the use of advanced imaging tools such as PET equipment in small animal imaging. By enabling real-time, noninvasive visualization of biological processes, small animal imaging supports faster drug development, deeper disease comprehension, and the formulation of more effective therapies. To illustrate, a May 2024 report from the UK’s Office for National Statistics highlighted that healthcare spending in the UK rose by 5.6% in nominal terms in 2023, with real-term growth of 2.8% in long-term health and social care expenditure in 2022. Such upward trends in healthcare funding are key growth drivers for the small animal imaging (in-vivo) market.

Segment Breakdown Highlighting Key Areas in the Small Animal Imaging (In-Vivo) Market

The small animal imaging (in-vivo) market is categorized into several important segments for better understanding:

1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, and Other Components

2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics

3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers

Access The Complete Small Animal Imaging (In-Vivo) Market Report:

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Further subcategories include:

– Micro-MRI: High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents

– Optical Imaging: In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems

– Nuclear Imaging: Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers

– Other Components: X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems

Innovations in Imaging Software Shaping Long-Term Trends in Small Animal Imaging (In-Vivo)

Leading companies in the small animal imaging (in-vivo) field are increasingly enhancing their software capabilities, particularly focusing on real-time kinetic analysis platforms. These advanced software solutions are designed to support more precise, quantitative, and high-throughput preclinical studies, especially in oncology and neuroscience. Unlike traditional static imaging snapshots, these platforms continuously capture dynamic bioluminescent signals over time, delivering richer data sets, improving reproducibility, and aiding in the accurate identification of peak signal phases. For example, in April 2024, US-based company Spectral Instruments Imaging released Aura 4.5, an updated version of its in vivo imaging software. This edition features a Kinetics mode that automates the acquisition of bioluminescent signals throughout their entire time course, including rise, plateau, and decay phases. The software then identifies peak intensity, helping researchers optimize sensitivity and biological accuracy while reducing manual labor. This upgrade is particularly valuable for longitudinal studies such as pharmacokinetics, gene expression, and infection models, enhancing workflow efficiency and data quality.

Key Players Driving Competition in the Small Animal Imaging (In-Vivo) Market

The small animal imaging (in-vivo) market is shaped by several prominent companies, including Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., and Rigaku Corporation. These organizations compete by advancing technological innovations, expanding product portfolios, and strengthening global reach.

Regional Demand Patterns and Growth Outlook in the Small Animal Imaging (In-Vivo) Market

In 2025, North America held the largest share of the small animal imaging (in-vivo) market, driven by significant investments and established research infrastructure. However, Europe is expected to emerge as the fastest-growing region during the forecast period. The market report also covers other key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of global demand and growth trajectories.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Small Animal Imaging (In-Vivo) Market By 2030 Based On Its 2026 Value?

The market size for small animal imaging (in-vivo) has seen rapid expansion in recent years. It is anticipated to increase from $3.15 billion in 2025 to $3.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.4%. This historical growth can be attributed to several factors such as the rise in preclinical research activities, augmented investments in drug discovery, an increase in academic research funding, the growing application of animal models in disease studies, and the availability of advanced imaging modalities.

The small animal imaging (in-vivo) market is set for significant expansion over the next few years. It is forecast to grow to $5.53 billion in 2030, achieving a compound annual growth rate (CAGR) of 11.8%. This anticipated growth throughout the forecast period is driven by increasing demand for precision medicine research tools, rising investments in translational research, the broadening of oncology and neurological studies, the growing adoption of AI-assisted diagnostics, and a heightened focus on real-time biological imaging. Prominent trends for the forecast period include the increasing adoption of multimodal imaging systems, the rising use of non-invasive in vivo imaging techniques, the growing integration of AI-based image analysis, the expansion of longitudinal disease monitoring studies, and an enhanced focus on high-resolution imaging capabilities.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp

What Market Drivers Are Helping Shape The Small Animal Imaging (In-Vivo) Market Expansion?

The small animal imaging (in vivo) market is expected to experience growth driven by increasing financial outlays in the healthcare sector. Healthcare expenditure represents the aggregate expenses for health services, including both public and private contributions, measured as a proportion of GDP. The rise in healthcare spending, coupled with heightened awareness regarding health, promotes self-care management concepts, within which PET equipment finds application in techniques such as small animal imaging. Small animal imaging (in vivo) offers advantages to the healthcare industry by allowing for noninvasive, real-time observation of biological processes, thereby accelerating drug development, deepening disease comprehension, and supporting the formulation of more efficacious treatments. For example, in May 2024, the Office for National Statistics, a UK-based government statistical organization, published a report stating that healthcare spending in the UK expanded by 5.6% in nominal terms during 2023, and long-term health and social care expenditure saw a real-term increase of 2.8% in 2022. Thus, the escalating expenditure within the healthcare domain is fueling the expansion of the small animal imaging (in-vivo) market.

How Is The Small Animal Imaging (In-Vivo) Market Examined Through Segment Analysis?

The small animal imaging (in-vivo) market covered in this report is segmented –

1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components

2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics

3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers

Subsegments:

1) By Micro-MRI: High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents

2) By Optical Imaging: In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems

3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers

4) By Other Components: X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems

Which Trends Are Supporting The Evolution Of The Small Animal Imaging (In-Vivo) Market?

Leading companies operating in the small animal imaging (In-Vivo) market are increasingly concentrating on advanced in vivo imaging software platforms, including real-time kinetic analysis modules, to satisfy the escalating requirement for more accurate, quantifiable, and high-throughput preclinical studies in areas such as oncology and neuroscience. Such software platforms facilitate the continuous capture and automated analysis of dynamic bioluminescent (BLI) signals over time, instead of traditional static single-timepoint observations, leading to richer kinetic curves, improved reproducibility, and better identification of peak signal phases. For example, in April 2024, Spectral Instruments Imaging, a US-based preclinical imaging technology firm, launched Aura 4.5, the latest version of its in vivo imaging software. Aura 4.5 introduces a Kinetics mode, which enables automated, real-time acquisition of bioluminescent signals throughout their complete time course, encompassing the rise, plateau, and decay phases. The software then identifies and reports the peak bioluminescent intensity, assisting researchers in maximizing sensitivity and biological accuracy. It also streamlines data acquisition and reduces manual intervention, thereby enhancing workflow efficiency for longitudinal studies. This feature-rich enhancement is especially beneficial for longitudinal, time-sensitive studies like pharmacokinetics, gene expression, or infection models.

Which Companies Form The Competitive Landscape Of The Small Animal Imaging (In-Vivo) Market?

Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation

Access The Complete Small Animal Imaging (In-Vivo) Market Report:

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Which Region Contributes The Most To The Small Animal Imaging (In-Vivo) Market?

North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Small Animal Imaging (In-Vivo) Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Browse Through More Reports Similar to the Global Small Animal Imaging (In-Vivo) Market 2026, By The Business Research Company

Veterinary Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-global-market-report

Veterinary Imaging Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-equipment-global-market-report

Preclinical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Small Animal Imaging (In-Vivo) Market Expected To Change From 2026 To 2030?

The small animal imaging (in-vivo) market has seen swift expansion in recent years. It is anticipated to increase from $3.15 billion in 2025 to $3.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.4%. This historical growth can be attributed to an uptick in preclinical research activities, rising investments in drug discovery, expanded academic research funding, a greater reliance on animal models for disease studies, and the accessibility of advanced imaging techniques.

The small animal imaging (in-vivo) market is projected to experience substantial growth over the coming years. This market is anticipated to reach a valuation of $5.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.8%. This projected expansion is primarily driven by factors such as the escalating demand for precision medicine research tools, increased investments in translational research, the broadening scope of oncology and neurological studies, the rising uptake of AI-assisted diagnostics, and a sharpened focus on real-time biological imaging. Key trends foreseen during this period encompass the growing adoption of multimodal imaging systems, a surge in the utilization of non-invasive in vivo imaging techniques, expanding integration of AI-based image analysis, the proliferation of longitudinal disease monitoring studies, and a heightened emphasis on high-resolution imaging capabilities.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

What Factors Are Contributing To The Growth Of The Small Animal Imaging (In-Vivo) Market?

The anticipated increase in spending within the healthcare sector is projected to boost the small animal imaging (in vivo) market’s growth. Healthcare expenditure defines the total cost of health services, encompassing both public and private contributions, presented as a percentage of GDP. Enhanced healthcare spending and greater health awareness foster self-care management, a practice where PET equipment is utilized in methods like small animal imaging. Small animal imaging (in vivo) supports the healthcare industry by allowing real-time, noninvasive visualization of biological processes, thus speeding up drug development, deepening disease understanding, and assisting in the creation of more effective treatments. For example, a May 2024 report from the Office for National Statistics, a UK government statistical body, indicated that healthcare spending in the UK rose by 5.6% in nominal terms in 2023, with long-term health and social care expenditure seeing a 2.8% increase in real terms in 2022. Consequently, the expanding investment in the healthcare sector is fueling the small animal imaging (in-vivo) market’s expansion.

What Are The Key Segment Divisions In The Small Animal Imaging (In-Vivo) Market Segment Structure?

The small animal imaging (in-vivo) market covered in this report is segmented –

1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components

2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics

3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers

Subsegments:

1) By Micro-MRI: High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents

2) By Optical Imaging: In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems

3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers

4) By Other Components: X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems

What Trends Are Shaping The Future Of The Small Animal Imaging (In-Vivo) Market?

Leading companies within the small animal imaging (In‑Vivo) sector are progressively emphasizing sophisticated in vivo imaging software platforms, including real-time kinetic analysis modules, to satisfy the growing need for more precise, quantitative, and efficient preclinical research in areas such as oncology and neuroscience. These platforms facilitate the uninterrupted capture and automated assessment of dynamic bioluminescent (BLI) signals over a period, moving beyond conventional static single-timepoint measurements. This approach delivers more comprehensive kinetic curves, enhances reproducibility, and improves the detection of peak signal phases. As an illustration, in April 2024, Spectral Instruments Imaging, an American firm specializing in preclinical imaging technology, introduced Aura 4.5, the newest iteration of their in vivo imaging software. Aura 4.5 features a Kinetics mode, which allows for automated, real-time collection of bioluminescent signals across their entire time progression, encompassing their ascent, stabilization, and decline phases. Subsequently, the software pinpoints and reports the maximum bioluminescent intensity, aiding researchers in optimizing sensitivity and biological precision. Additionally, it streamlines the process of data acquisition and minimizes manual input, thereby boosting workflow efficiency for extended observational studies. This enhanced update, rich in features, proves particularly beneficial for longitudinal, time-critical investigations like pharmacokinetics, gene expression analysis, or infection models.

Which Organizations Are Engaged In The Small Animal Imaging (In-Vivo) Market?

Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation

Get The Full Small Animal Imaging (In-Vivo) Market Report:

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Which Region Accounts For The Largest Portion Of The Small Animal Imaging (In-Vivo) Market?

North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Small Animal Imaging (In-Vivo) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Browse Through More Reports Similar to the Global Small Animal Imaging (In-Vivo) Market 2026, By The Business Research Company

Veterinary Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-global-market-report

Veterinary Imaging Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-equipment-global-market-report

Preclinical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Small Animal Imaging (In-Vivo) Market At The End Of The 2026–2030 Forecast Period?

The small animal imaging (in-vivo) market has experienced rapid expansion in recent years. This market is set to expand from $3.15 billion in 2025 to $3.54 billion in 2026, at a compound annual growth rate (CAGR) of 12.4%. During the preceding period, this expansion was driven by several factors, including the rise in preclinical research activities, increased investments in drug discovery, growth in academic research funding, a greater reliance on animal models for disease investigations, and the introduction of advanced imaging modalities.

The small animal imaging (in-vivo) market is projected for significant expansion in the coming years. This market is forecast to reach $5.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.8%. Contributing factors to this growth include a rise in demand for precision medicine research tools, increased investments in translational research, an expansion of oncology and neurological studies, greater adoption of AI-assisted diagnostics, and a heightened focus on real-time biological imaging. Key trends anticipated during this period involve a surge in the adoption of multimodal imaging systems, increased utilization of non-invasive in vivo imaging techniques, expanding integration of AI-based image analysis, a broadening of longitudinal disease monitoring studies, and a stronger emphasis on high-resolution imaging capabilities.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp

What Drivers Are Shaping The Future Growth Of The Small Animal Imaging (In-Vivo) Market?

Increased spending within the healthcare sector is projected to drive the expansion of the small animal imaging (in vivo) market. Healthcare expenditure encompasses the total public and private costs of healthcare relative to GDP. The upward trend in healthcare spending, coupled with greater health awareness, fosters self-care management practices that utilize PET equipment in methods like small animal imaging. Small animal imaging (in vivo) supports the healthcare industry by allowing real-time, noninvasive visualization of biological processes, accelerating drug development, enhancing disease comprehension, and aiding in the creation of more effective treatments. As an illustration, a May 2024 report by the UK-based Office for National Statistics indicated that healthcare spending in the UK grew by 5.6% in nominal terms in 2023, with long-term health and social care expenditure seeing a 2.8% increase in real terms in 2022. Consequently, the rising expenditure in the healthcare sector is a key driver for the small animal imaging (in-vivo) market’s growth.

What Segment Types Make Up The Small Animal Imaging (In-Vivo) Market?

The small animal imaging (in-vivo) market covered in this report is segmented –

1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components

2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics

3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers

Subsegments:

1) By Micro-MRI: High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents

2) By Optical Imaging: In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems

3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers

4) By Other Components: X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems

Which Market Trends Are Creating New Opportunities In The Small Animal Imaging (In-Vivo) Market?

Leading firms within the small animal imaging (In-Vivo) market are dedicating more attention to sophisticated in vivo imaging software platforms, including real-time kinetic analysis modules, to address the growing need for more precise, quantifiable, and high-volume preclinical research in areas such as oncology and neuroscience. These platforms facilitate the continuous acquisition and automated evaluation of dynamic bioluminescent (BLI) signals across durations, contrasting with conventional static, single-timepoint images. This approach results in more comprehensive kinetic curves, enhanced reproducibility, and superior identification of peak signal stages. An example of this trend occurred in April 2024, when Spectral Instruments Imaging, a US-based company specializing in preclinical imaging technology, released Aura 4.5, its newest iteration of in vivo imaging software. Aura 4.5 incorporates a Kinetics mode, enabling the automated, real-time collection of bioluminescent signals across their entire time course, encompassing the rise, plateau, and decay phases. Subsequently, the software pinpoints and reports the maximum bioluminescent intensity, assisting researchers in optimizing sensitivity and biological precision. Furthermore, it optimizes data collection and lessens the need for manual input, thereby improving workflow efficiency for longitudinal research. This enhanced upgrade, rich in features, proves particularly beneficial for longitudinal, time-critical investigations like those involving pharmacokinetics, gene expression, or infection models.

Who Are The Key Players Driving Competition In The Small Animal Imaging (In-Vivo) Market?

Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation

Read the full small animal imaging (in-vivo) market report here:

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Which Geographic Regions Are Influencing Demand In The Small Animal Imaging (In-Vivo) Market?

North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Small Animal Imaging (In-Vivo) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7303&type=smp

Browse Through More Reports Similar to the Global Small Animal Imaging (In-Vivo) Market 2026, By The Business Research Company

Veterinary Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-global-market-report

Veterinary Imaging Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-equipment-global-market-report

Preclinical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Small Animal Imaging (In-Vivo) Market At The End Of The 2026–2030 Forecast Period?

The small animal imaging (in-vivo) market has experienced rapid expansion in recent years. This market is set to expand from $3.15 billion in 2025 to $3.54 billion in 2026, at a compound annual growth rate (CAGR) of 12.4%. During the preceding period, this expansion was driven by several factors, including the rise in preclinical research activities, increased investments in drug discovery, growth in academic research funding, a greater reliance on animal models for disease investigations, and the introduction of advanced imaging modalities.

The small animal imaging (in-vivo) market is projected for significant expansion in the coming years. This market is forecast to reach $5.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.8%. Contributing factors to this growth include a rise in demand for precision medicine research tools, increased investments in translational research, an expansion of oncology and neurological studies, greater adoption of AI-assisted diagnostics, and a heightened focus on real-time biological imaging. Key trends anticipated during this period involve a surge in the adoption of multimodal imaging systems, increased utilization of non-invasive in vivo imaging techniques, expanding integration of AI-based image analysis, a broadening of longitudinal disease monitoring studies, and a stronger emphasis on high-resolution imaging capabilities.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp

What Drivers Are Shaping The Future Growth Of The Small Animal Imaging (In-Vivo) Market?

Increased spending within the healthcare sector is projected to drive the expansion of the small animal imaging (in vivo) market. Healthcare expenditure encompasses the total public and private costs of healthcare relative to GDP. The upward trend in healthcare spending, coupled with greater health awareness, fosters self-care management practices that utilize PET equipment in methods like small animal imaging. Small animal imaging (in vivo) supports the healthcare industry by allowing real-time, noninvasive visualization of biological processes, accelerating drug development, enhancing disease comprehension, and aiding in the creation of more effective treatments. As an illustration, a May 2024 report by the UK-based Office for National Statistics indicated that healthcare spending in the UK grew by 5.6% in nominal terms in 2023, with long-term health and social care expenditure seeing a 2.8% increase in real terms in 2022. Consequently, the rising expenditure in the healthcare sector is a key driver for the small animal imaging (in-vivo) market’s growth.

What Segment Types Make Up The Small Animal Imaging (In-Vivo) Market?

The small animal imaging (in-vivo) market covered in this report is segmented –

1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components

2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics

3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers

Subsegments:

1) By Micro-MRI: High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents

2) By Optical Imaging: In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems

3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers

4) By Other Components: X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems

Which Market Trends Are Creating New Opportunities In The Small Animal Imaging (In-Vivo) Market?

Leading firms within the small animal imaging (In-Vivo) market are dedicating more attention to sophisticated in vivo imaging software platforms, including real-time kinetic analysis modules, to address the growing need for more precise, quantifiable, and high-volume preclinical research in areas such as oncology and neuroscience. These platforms facilitate the continuous acquisition and automated evaluation of dynamic bioluminescent (BLI) signals across durations, contrasting with conventional static, single-timepoint images. This approach results in more comprehensive kinetic curves, enhanced reproducibility, and superior identification of peak signal stages. An example of this trend occurred in April 2024, when Spectral Instruments Imaging, a US-based company specializing in preclinical imaging technology, released Aura 4.5, its newest iteration of in vivo imaging software. Aura 4.5 incorporates a Kinetics mode, enabling the automated, real-time collection of bioluminescent signals across their entire time course, encompassing the rise, plateau, and decay phases. Subsequently, the software pinpoints and reports the maximum bioluminescent intensity, assisting researchers in optimizing sensitivity and biological precision. Furthermore, it optimizes data collection and lessens the need for manual input, thereby improving workflow efficiency for longitudinal research. This enhanced upgrade, rich in features, proves particularly beneficial for longitudinal, time-critical investigations like those involving pharmacokinetics, gene expression, or infection models.

Who Are The Key Players Driving Competition In The Small Animal Imaging (In-Vivo) Market?

Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation

Read the full small animal imaging (in-vivo) market report here:

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Which Geographic Regions Are Influencing Demand In The Small Animal Imaging (In-Vivo) Market?

North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Small Animal Imaging (In-Vivo) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7303&type=smp

Browse Through More Reports Similar to the Global Small Animal Imaging (In-Vivo) Market 2026, By The Business Research Company

Veterinary Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-global-market-report

Veterinary Imaging Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-equipment-global-market-report

Preclinical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Small Animal Imaging (In-Vivo) Market At The End Of The 2026–2030 Forecast Period?

The small animal imaging (in-vivo) market has experienced rapid expansion in recent years. This market is set to expand from $3.15 billion in 2025 to $3.54 billion in 2026, at a compound annual growth rate (CAGR) of 12.4%. During the preceding period, this expansion was driven by several factors, including the rise in preclinical research activities, increased investments in drug discovery, growth in academic research funding, a greater reliance on animal models for disease investigations, and the introduction of advanced imaging modalities.

The small animal imaging (in-vivo) market is projected for significant expansion in the coming years. This market is forecast to reach $5.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.8%. Contributing factors to this growth include a rise in demand for precision medicine research tools, increased investments in translational research, an expansion of oncology and neurological studies, greater adoption of AI-assisted diagnostics, and a heightened focus on real-time biological imaging. Key trends anticipated during this period involve a surge in the adoption of multimodal imaging systems, increased utilization of non-invasive in vivo imaging techniques, expanding integration of AI-based image analysis, a broadening of longitudinal disease monitoring studies, and a stronger emphasis on high-resolution imaging capabilities.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp

What Drivers Are Shaping The Future Growth Of The Small Animal Imaging (In-Vivo) Market?

Increased spending within the healthcare sector is projected to drive the expansion of the small animal imaging (in vivo) market. Healthcare expenditure encompasses the total public and private costs of healthcare relative to GDP. The upward trend in healthcare spending, coupled with greater health awareness, fosters self-care management practices that utilize PET equipment in methods like small animal imaging. Small animal imaging (in vivo) supports the healthcare industry by allowing real-time, noninvasive visualization of biological processes, accelerating drug development, enhancing disease comprehension, and aiding in the creation of more effective treatments. As an illustration, a May 2024 report by the UK-based Office for National Statistics indicated that healthcare spending in the UK grew by 5.6% in nominal terms in 2023, with long-term health and social care expenditure seeing a 2.8% increase in real terms in 2022. Consequently, the rising expenditure in the healthcare sector is a key driver for the small animal imaging (in-vivo) market’s growth.

What Segment Types Make Up The Small Animal Imaging (In-Vivo) Market?

The small animal imaging (in-vivo) market covered in this report is segmented –

1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components

2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics

3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers

Subsegments:

1) By Micro-MRI: High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents

2) By Optical Imaging: In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems

3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers

4) By Other Components: X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems

Which Market Trends Are Creating New Opportunities In The Small Animal Imaging (In-Vivo) Market?

Leading firms within the small animal imaging (In-Vivo) market are dedicating more attention to sophisticated in vivo imaging software platforms, including real-time kinetic analysis modules, to address the growing need for more precise, quantifiable, and high-volume preclinical research in areas such as oncology and neuroscience. These platforms facilitate the continuous acquisition and automated evaluation of dynamic bioluminescent (BLI) signals across durations, contrasting with conventional static, single-timepoint images. This approach results in more comprehensive kinetic curves, enhanced reproducibility, and superior identification of peak signal stages. An example of this trend occurred in April 2024, when Spectral Instruments Imaging, a US-based company specializing in preclinical imaging technology, released Aura 4.5, its newest iteration of in vivo imaging software. Aura 4.5 incorporates a Kinetics mode, enabling the automated, real-time collection of bioluminescent signals across their entire time course, encompassing the rise, plateau, and decay phases. Subsequently, the software pinpoints and reports the maximum bioluminescent intensity, assisting researchers in optimizing sensitivity and biological precision. Furthermore, it optimizes data collection and lessens the need for manual input, thereby improving workflow efficiency for longitudinal research. This enhanced upgrade, rich in features, proves particularly beneficial for longitudinal, time-critical investigations like those involving pharmacokinetics, gene expression, or infection models.

Who Are The Key Players Driving Competition In The Small Animal Imaging (In-Vivo) Market?

Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation

Read the full small animal imaging (in-vivo) market report here:

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Which Geographic Regions Are Influencing Demand In The Small Animal Imaging (In-Vivo) Market?

North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Small Animal Imaging (In-Vivo) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7303&type=smp

Browse Through More Reports Similar to the Global Small Animal Imaging (In-Vivo) Market 2026, By The Business Research Company

Veterinary Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-global-market-report

Veterinary Imaging Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-equipment-global-market-report

Preclinical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

How much is the Small Animal Imaging (In-Vivo) Market valued at in 2026, and what valuation is forecast for 2030?

The small animal imaging (in-vivo) market has seen substantial expansion in recent years. This market is expected to increase from $3.15 billion in 2025 to $3.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.4%. The historic period’s growth drivers include an uptick in preclinical research activities, increasing investments in drug discovery, expanded academic research funding, the rising utilization of animal models in disease studies, and the availability of advanced imaging modalities.

The small animal imaging (in-vivo) market size is anticipated to experience substantial growth in the coming years. It is projected to reach $5.53 billion by 2030, with a compound annual growth rate (CAGR) of 11.8%. This growth during the forecast period can be linked to factors such as an escalating demand for precision medicine research tools, increasing investments in translational research, the expansion of oncology and neurological studies, a rising adoption of AI-assisted diagnostics, and a greater emphasis on real-time biological imaging. Prominent trends throughout this period include the increased uptake of multimodal imaging systems, a growing application of non-invasive in vivo imaging techniques, the deepening integration of AI-based image analysis, the broadening of longitudinal disease monitoring studies, and an amplified focus on high-resolution imaging capabilities.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp

What Drivers Are Influencing The Growth Of The Small Animal Imaging (In-Vivo) Market?

Increased expenditure in the healthcare sector is anticipated to propel the future growth of the small animal imaging (in vivo) market. This healthcare expenditure encompasses the total public and private costs of health care as a percentage of GDP. A rise in healthcare spending coupled with growing health awareness promotes self-care management, where PET equipment is utilized in methods like small animal imaging. Small animal imaging (in vivo) benefits the healthcare sector by enabling the noninvasive, real-time visualization of biological processes, thereby accelerating drug development, deepening disease understanding, and facilitating the creation of more effective therapies. As an illustration, a report released in May 2024 by the Office for National Statistics, a UK-based governmental statistical body, stated that healthcare spending in the UK rose by 5.6% in nominal terms in 2023, with long-term health and social care expenditure showing a 2.8% increase in real terms in 2022. Hence, the increasing financial outlay for the healthcare sector is driving the expansion of the small animal imaging (in vivo) market.

How Is The Small Animal Imaging (In-Vivo) Market Organized Into Various Segments?

The small animal imaging (in-vivo) market covered in this report is segmented –

1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components

2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics

3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers

Subsegments:

1) By Micro-MRI: High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents

2) By Optical Imaging: In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems

3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers

4) By Other Components: X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems

Which Innovation Trends Are Advancing Developments Within The Small Animal Imaging (In-Vivo) Market?

Major companies operating in the small animal imaging (In-Vivo) market are increasingly prioritizing advanced in vivo imaging software platforms, such as those with real-time kinetic analysis modules. This focus aims to meet the growing need for more accurate, quantitative, and high-throughput preclinical studies in fields like oncology and neuroscience. These software solutions enable continuous capture and automated analysis of dynamic bioluminescent (BLI) signals over time, a departure from traditional static single-timepoint snapshots. This methodology yields richer kinetic curves, improves reproducibility, and facilitates better identification of peak signal phases. For example, in April 2024, Spectral Instruments Imaging, a US-based preclinical imaging technology company, launched Aura 4.5, the most recent version of its in vivo imaging software. Aura 4.5 introduces a Kinetics mode, which permits automated, real-time acquisition of bioluminescent signals across their entire time course, including rise, plateau, and decay phases. The software subsequently identifies and reports the peak bioluminescent intensity, aiding researchers in maximizing sensitivity and biological accuracy. It also streamlines data acquisition processes and reduces the need for manual intervention, thus enhancing workflow efficiency for longitudinal studies. This updated, feature-rich software is especially valuable for longitudinal, time-sensitive research such as pharmacokinetics, gene expression, or infection models.

Who Are The Major Companies Operating In The Small Animal Imaging (In-Vivo) Market?

Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Which Regions Are Poised For Strategic Growth In The Small Animal Imaging (In-Vivo) Market?

North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Small Animal Imaging (In-Vivo) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7303&type=smp

Browse Through More Reports Similar to the Global Small Animal Imaging (In-Vivo) Market 2026, By The Business Research Company

Veterinary Imaging Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-global-market-report

Veterinary Imaging Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-equipment-global-market-report

Preclinical Imaging Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company